Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments

肝细胞癌 医学 内科学 数字聚合酶链反应 生物标志物 肿瘤科 胃肠病学 突变 癌症研究 聚合酶链反应 生物 基因 生物化学
作者
Claudia Campani,Sandrine Imbeaud,Gabrielle Couchy,Marianne Ziol,Théo Z. Hirsch,Sandra Rebouissou,Bénédicte Noblet,Pierre Nahon,Katia Hormigos,Sabrina Sidali,Olivier Séror,Valérie Taly,Nathalie Ganne–Carrié,Pierre Laurent‐Puig,Jessica Zucman‐Rossi,Jean‐Charles Nault
出处
期刊:Gut [BMJ]
卷期号:: gutjnl-331956 被引量:1
标识
DOI:10.1136/gutjnl-2024-331956
摘要

Objective Circulating tumour DNA (ctDNA) is a promising non-invasive biomarker in cancer. We aim to assess the dynamic of ctDNA in patients with hepatocellular carcinoma (HCC). Design We analysed 772 plasmas from 173 patients with HCC collected at the time of diagnosis or treatment (n=502), 24 hours after locoregional treatment (n=154) and during follow-up (n=116). For controls, 56 plasmas from patients with chronic liver disease without HCC were analysed. All samples were analysed for cell free DNA (cfDNA) concentration, and for mutations in TERT promoter, CTNNB1 , TP53 , PIK3CA and NFE2L2 by sequencing and droplet-based digital PCR. Results were compared with 232 corresponding tumour samples. Results In patients with active HCC, 40.2% of the ctDNA was mutated vs 14.6% in patients with inactive HCC and 1.8% in controls (p<0.001). In active HCC, we identified 27.5% of mutations in TERT promoter, 21.3% in TP53 , 13.1% in CTNNB1 , 0.4% in PIK3CA and 0.2% in NFE2L2, most of the times similar to those identified in the corresponding tumour. CtDNA mutation rate increased with advanced tumour stages (p<0.001). In 103 patients treated by percutaneous ablation, the presence and number of mutations in the ctDNA before treatment were associated with higher risk of death (p=0.001) and recurrence (p<0.001). Interestingly, cfDNA concentration and detectable mutations increased 24 hours after a locoregional treatment. Among 356 plasmas collected in 53 patients treated by systemic treatments, we detected mutations at baseline in 60.4% of the cases. In patients treated by atezolizumab-bevacizumab, persistence of mutation in ctDNA was associated with radiological progression (63.6% vs 36.4% for disappearance, p=0.019). In two patients progressing under systemic treatments, we detected the occurrence of mutations in CTNNB1 in the plasma that was subclonal in the tumour for one patient and not detectable in the tumour for the other one. Conclusion ctDNA offers dynamic information reflecting tumour biology. It represents a non-invasive tool useful to guide HCC clinical management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jiejie完成签到,获得积分10
4秒前
sun完成签到,获得积分10
5秒前
8秒前
嚣张的豆豆完成签到,获得积分10
8秒前
繁荣的念双完成签到,获得积分10
9秒前
共享精神应助米九采纳,获得10
9秒前
小蘑菇应助小羊要加油采纳,获得10
10秒前
完美世界应助研友_LaV1xn采纳,获得10
11秒前
leijh123完成签到,获得积分20
12秒前
xv完成签到,获得积分10
12秒前
CGBY完成签到 ,获得积分10
13秒前
科研通AI2S应助科研通管家采纳,获得30
15秒前
orixero应助科研通管家采纳,获得10
15秒前
wanci应助科研通管家采纳,获得10
16秒前
Byby应助柚屿采纳,获得30
16秒前
16秒前
研友_VZG7GZ应助科研通管家采纳,获得10
16秒前
香蕉觅云应助科研通管家采纳,获得10
16秒前
科研通AI2S应助科研通管家采纳,获得10
16秒前
16秒前
SciGPT应助科研通管家采纳,获得10
16秒前
Mobius完成签到,获得积分10
16秒前
17秒前
19秒前
训仔完成签到,获得积分10
19秒前
20秒前
22秒前
24秒前
赘婿应助dudu采纳,获得10
24秒前
24秒前
科目三应助AmyHu采纳,获得10
25秒前
江上钓太公完成签到,获得积分10
27秒前
斯文败类应助哈哈哈哈采纳,获得10
28秒前
niumi190发布了新的文献求助20
29秒前
礽粥粥发布了新的文献求助10
29秒前
瘦瘦的睫毛膏完成签到,获得积分10
30秒前
31秒前
NexusExplorer应助caikeke采纳,获得10
32秒前
李健应助QWE采纳,获得10
33秒前
万能图书馆应助雪雪子采纳,获得10
33秒前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
CLSI EP47 Evaluation of Reagent Carryover Effects on Test Results, 1st Edition 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
"Sixth plenary session of the Eighth Central Committee of the Communist Party of China" 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3055401
求助须知:如何正确求助?哪些是违规求助? 2712227
关于积分的说明 7430195
捐赠科研通 2357037
什么是DOI,文献DOI怎么找? 1248528
科研通“疑难数据库(出版商)”最低求助积分说明 606737
版权声明 596093